These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 8452147)
21. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408 [TBL] [Abstract][Full Text] [Related]
22. Risk of liver disease in HCV-seropositive kidney transplant recipients. Rohr MS; Lesniewski RR; Rubin CA; Johnson RG; Heise ER; McDonald JC; Adams PL Ann Surg; 1993 May; 217(5):512-6; discussion 516-7. PubMed ID: 8387764 [TBL] [Abstract][Full Text] [Related]
23. Chronic active hepatitis without hepatitis B antigenemia in renal transplant recipients. Report of three cases. Freiberger Z; Anuras S; Koff RS; Bonney WW Gastroenterology; 1974 Jun; 66(6):1187-94. PubMed ID: 4597752 [No Abstract] [Full Text] [Related]
24. Peritoneoscopic liver biopsy findings in asymptomatic chronic HBsAg carriers with normal liver function tests and no hepatomegaly. Chon CY; Han KH; Lee KS; Moon YM; Kang JK; Park IS; Park C Yonsei Med J; 1996 Oct; 37(5):295-301. PubMed ID: 8997161 [TBL] [Abstract][Full Text] [Related]
25. Laparoscopic evaluation of liver disease in chronic renal failure prior to renal transplantation. Ribeiro A; Reddy R; Bernstein DE; Roth D; Jeffers L; Schiff ER Gastrointest Endosc; 1997 Jun; 45(6):503-7. PubMed ID: 9199909 [TBL] [Abstract][Full Text] [Related]
26. Hemosiderosis and hemochromatosis in renal transplant recipients. Clinical and pathological features, diagnostic correlations, predisposing factors, and treatment. Rao KV; Anderson WR Am J Nephrol; 1985; 5(6):419-30. PubMed ID: 3909817 [TBL] [Abstract][Full Text] [Related]
27. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580 [TBL] [Abstract][Full Text] [Related]
28. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Huraib S; Iqbal A; Tanimu D; Abdullah A Am J Nephrol; 2001; 21(6):435-40. PubMed ID: 11799259 [TBL] [Abstract][Full Text] [Related]
29. Clinical course of hepatitis C virus infection in renal transplant recipients. Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869 [TBL] [Abstract][Full Text] [Related]
30. [Outcome of the kidney transplant recipients with chronic hepatitis B virus]. Chen ZY; Lai YT; Huang WJ; Cai YQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):392-5. PubMed ID: 16859131 [TBL] [Abstract][Full Text] [Related]
31. Biopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication. Whitcomb E; Choi WT; Jerome KR; Cook L; Landis C; Ahn J; Te HS; Esfeh J; Hanouneh IA; Rayhill SC; Gibson W; Plesec T; Koo J; Wang HL; Hart J; Pai RK; Westerhoff M Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1279-1285. PubMed ID: 28501538 [TBL] [Abstract][Full Text] [Related]
32. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942 [TBL] [Abstract][Full Text] [Related]
33. Chronic hepatitis in kidney allograft recipients. Pol S; Debure A; Degott C; Carnot F; Legendre C; Brechot C; Kreis H Lancet; 1990 Apr; 335(8694):878-80. PubMed ID: 1969984 [TBL] [Abstract][Full Text] [Related]
34. Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis. Degott C; Degos F; Jungers P; Naret C; Courouce AM; Potet F; Crosnier J Liver; 1983 Dec; 3(6):377-84. PubMed ID: 6366422 [TBL] [Abstract][Full Text] [Related]
35. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection. Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434 [TBL] [Abstract][Full Text] [Related]
36. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Demetris AJ; Todo S; Van Thiel DH; Fung JJ; Iwaki Y; Sysyn G; Ming W; Trager J; Starzl TE Am J Pathol; 1990 Sep; 137(3):667-76. PubMed ID: 2399936 [TBL] [Abstract][Full Text] [Related]
37. Are posttransplantation protocol liver biopsies useful in the long term? Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis B surface antigen carriers--to biopsy or not to biopsy. Koretz RL; Lewin KJ; Rebhun DJ; Gitnick GL Gastroenterology; 1978 Nov; 75(5):860-3. PubMed ID: 700327 [TBL] [Abstract][Full Text] [Related]
39. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus-associated liver disease after renal transplantation. Disler PB; Meyers AM; Kew MC; Myburgh JA S Afr Med J; 1981 Jan; 59(4):97-8. PubMed ID: 7006108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]